Transgene expands myvac platform into non-small cell lung cancer with TG4070
Fusion Antibodies secures Canadian patent allowance for antibody library technology
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
Sanofi's Sarclisa SC formulation gains Japanese approval to treat multiple myeloma
Arletta Pharma Solutions names new chief medical officer
Kither Biotech completes Phase 1 KIT2014 clinical study
Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b
uniQure reports initial six‑month data from first AMT‑260 dose cohort
Incyte Japan wins approval for Minjuvi combination therapy in relapsed or refractory DLBCL
Teijin and Merz secure Japanese approval for additional XEOMIN indications
Alvotech raises USD165m in public offering and private placement
Oncoinvent reports recruitment milestone in Phase 2 study of Radspherin in ovarian cancer
Nortiva Bio launches to develop long-acting oral medicines using LYNX platform